Consideration of IRI risk facets during donor-recipient coordinating may help out with optimizing graft utilization and LT results. Also, identification of threat aspects of IRI-associated EAD may guide diligent administration and possible timely graft replacement.Advanced clear mobile carcinomas originating from both ovaries and kidneys with…[Read more]